Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models

por Rupert, Christofer, Dell’ Aversana, Carmela, Mosca, Laura, Montanaro, Vittorino, Arcaniolo, Davide, De Sio, Marco, Bilancio, Antonio, Altucci, Lucia, Palinski, Wulf, Pili, Roberto, de Nigris, Filomena
Publicado 2023

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study

por Di Lorenzo, Giuseppe, Buonerba, Carlo, Bellelli, Teresa, Romano, Concetta, Montanaro, Vittorino, Ferro, Matteo, Benincasa, Alfonso, Ribera, Dario, Lucarelli, Giuseppe, De Cobelli, Ottavio, Sonpavde, Guru, De Placido, Sabino
Publicado 2015

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis

por Mignogna, Chiara, Staibano, Stefania, Altieri, Vincenzo, De Rosa, Gaetano, Pannone, Giuseppe, Santoro, Angela, Zamparese, Rosanna, D'Armiento, Massimino, Rocchetti, Romualdo, Mezza, Ernesto, Nasti, Mario, Strazzullo, Viviana, Montanaro, Vittorino, Mascolo, Massimo, Bufo, Pantaleo
Publicado 2006

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study

por Bosso, Davide, Pagliuca, Martina, Sonpavde, Guru, Pond, Gregory, Lucarelli, Giuseppe, Rossetti, Sabrina, Facchini, Gaetano, Scagliarini, Sarah, Cartenì, Giacomo, Daniele, Bruno, Morelli, Franco, Ferro, Matteo, Puglia, Livio, Izzo, Michela, Montanaro, Vittorino, Bellelli, Teresa, Vitrone, Francesca, De Placido, Sabino, Buonerba, Carlo, Di Lorenzo, Giuseppe
Publicado 2017